investorscraft@gmail.com

Intrinsic ValueNature's Sunshine Products, Inc. (NATR)

Previous Close$25.22
Intrinsic Value
Upside potential
Previous Close
$25.22

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Nature's Sunshine Products, Inc. operates in the health and wellness industry, specializing in the manufacturing and distribution of natural health products, including dietary supplements, personal care items, and herbal remedies. The company primarily generates revenue through direct sales, leveraging a global network of independent distributors and a strong e-commerce platform. Its product portfolio targets health-conscious consumers seeking plant-based and scientifically validated solutions, positioning it as a niche player in the competitive wellness market. Nature's Sunshine differentiates itself through rigorous quality control, proprietary formulations, and a vertically integrated supply chain, which enhances product consistency and cost efficiency. The company operates in over 40 countries, with a particularly strong presence in North America, Europe, and Asia, allowing it to capitalize on growing global demand for natural health products. Despite facing competition from larger CPG companies, Nature's Sunshine maintains a loyal customer base due to its heritage as a pioneer in herbal supplements and its focus on holistic wellness.

Revenue Profitability And Efficiency

In FY 2024, Nature's Sunshine reported revenue of $454.4 million, reflecting its steady demand in the health supplements market. Net income stood at $7.7 million, with diluted EPS of $0.40, indicating modest profitability. Operating cash flow was $25.3 million, supported by efficient working capital management, while capital expenditures of $10.97 million suggest ongoing investments in production and distribution capabilities.

Earnings Power And Capital Efficiency

The company's earnings power is tempered by competitive pressures and moderate margins, though its asset-light model and direct-to-consumer approach help sustain capital efficiency. With no dividend payouts, retained earnings are likely reinvested into growth initiatives or debt reduction, aligning with its long-term strategic priorities.

Balance Sheet And Financial Health

Nature's Sunshine maintains a solid balance sheet, with $84.7 million in cash and equivalents providing liquidity. Total debt is relatively low at $14.2 million, indicating a conservative leverage profile. The strong cash position and manageable debt levels suggest financial flexibility to navigate market fluctuations or pursue selective expansion opportunities.

Growth Trends And Dividend Policy

Revenue trends reflect stable demand for natural health products, though growth may be constrained by market saturation in key regions. The company does not currently pay dividends, opting instead to reinvest cash flows into operational improvements and potential acquisitions to drive future expansion.

Valuation And Market Expectations

With a modest net income and EPS, the market likely values Nature's Sunshine based on its niche positioning and cash flow stability rather than aggressive growth prospects. Investor expectations may center on its ability to sustain margins and capitalize on wellness industry tailwinds.

Strategic Advantages And Outlook

Nature's Sunshine's vertically integrated supply chain and brand legacy provide competitive advantages in quality assurance and customer trust. The outlook hinges on its ability to innovate within the natural health space while optimizing its global distribution network. Challenges include rising input costs and competition, but its strong balance sheet offers resilience.

Sources

Company 10-K filings, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount